Back to results
US 2022/0282297 A1Published application
Biosynthetic production of steviol glycoside rebaudioside d4 from rebaudioside e
AssigneeConagen Inc.
InventorsGuohong Mao, Jacob Edward Vick, Michael Batten, Yang Luo, Yilin Wu, Xiaodan Yu
Life of this patent
Estimating the term…
Abstract
The present invention relates, in some aspects, to the production of steviol glycoside rebaudioside D4 through the use of rebaudioside E. In some aspects, the invention relates to mutant CP1 enzymes, mutant HV1 enzymes as well as host cells and methods utilizing such enzymes, such as to produce rebaudioside D4.
Claims20
-44. (canceled)
A recombinant polypeptide comprising an amino acid sequence at least 80% identical to any one of SEQ ID NOs:
- 3, 5, 7, 9, 11, and 13.
Dependencies are inferred from the claim text.